Kathleen Creech - Mar 1, 2025 Form 4 Insider Report for DIEBOLD NIXDORF, Inc (DBD)

Role
EVP, CHRO
Signature
/s/Elizabeth Radigan, Attorney-in-fact for Kathleen Creech
Stock symbol
DBD
Transactions as of
Mar 1, 2025
Transactions value $
-$37,551
Form type
4
Date filed
3/3/2025, 05:30 PM
Previous filing
Sep 17, 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction DBD Common Stock Award $0 +8.17K +104.67% $0.00 16K Mar 1, 2025 Direct F1, F2
transaction DBD Common Stock Tax liability -$37.6K -849 -5.31% $44.23 15.1K Mar 1, 2025 Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Award of Restricted Stock Units granted under the Diebold Nixdorf, Incorporated 2023 Equity and Incentive Plan, as amended, and vesting in annual increments of 1/3, 1/3, 1/3 beginning one year from the date of grant; each Restricted Stock Unit represents a contingent right to receive one share of Diebold Nixdorf, Incorporated common stock.
F2 Number includes Restricted Stock Units.
F3 Shares withheld pursuant to exercise of tax withholding right under the 2023 Equity and Incentive Plan, as amended.